Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
A&O Shearman demonstrates capabilities in both life sciences and tech patents and has a strong track record in all major litigation venues. The team is particularly strong on Hatch-Waxman on both the brand and generic side. The team is led by New York’s Elizabeth Holland, a first-chair trial lawyer sought after by pharma, biotech and medical device companies. In Boston, John Bennett specializes in Hatch-Waxman and BPCIA cases. William James, in Washington DC, is another key Hatch-Waxman specialist who also focuses on IPR and appellate proceedings.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The A&O Shearman team is nothing but excellent. Very knowledgeable about our industry and the law, always available, providing practical no-nonsense advice.’
‘Tom (Thomas) Makin is outstanding. He is always available, excellent understanding of our industry, situation and how to navigate.’
Clients clés
- University of Pennsylvania
- Alcon
Points forts
- Advised University of Pennsylvania in a patent infringement litigation asserting its U.S. Patent No. 7,625,558 (methods of treating cancer tumors) against Genentech's multi-billion dollar products Herceptin, Perjeta, and Phesgo.
- Advised Alcon in the District of Delaware against Padagis Israel Pharmaceuticals Ltd., Padgis US LLC, and Padagis LLC (“Padagis”).